1
research in developing catalytic processes as well as in developing processes. The MIT-patented technology involves the preparation of arylamines from amines and activated aromatic compounds when a palladium or nickel catalyst and base are present. A patent on diarylether condensation is also covered. Performance Chemicals Europe, Jul-Aug 2002, 17 (4), 13 & Speciality Chemicals, Jul-Aug 2002, 22 (7), 6 & Chemical Engineering World, Jul 2002, 37 (7), 38 BP catalyst expertise offered worldwide BP is to make its new catalyst for use in fixed-bed maleic anhydride production available to companies around the world. BP is using the catalyst, BP-5, in the fixed-bed manufacture of maleic anhydride from butane. BP-5 can be used by benzene-based producers of maleic anhydride which want to switch to butane. European Chemical News, 19 Aug 2002, 77 (2018), 28 & Press release from BP Catalyst and Licensing, 150 West Warrenville Road, Naperville, IL 60563, USA. Tel: + 1 630 961 6506. Fax: +1 630 961 7663. Website: http://www.bp.com (7 Aug 2002) Celanese-Novolen metallocenes pact New and improved metallocenes, co- catalysts, and metallocene catalysts are to be jointly developed by Celanese and Novolen Technology Holdings in order to accelerate the commercialization of metallocene technology and broaden application fields. Chemical Week, 31 Jul 2002, 164 (30), 8 & European Chemical News, 19 Aug 2002, 77 (2018), 26 & Plastics and Rubber Weekly, 23 Aug 2002, 7 & Chemical Market Reporter, 5 Aug 2002 (Website: http://www.chemicalmarketreporter.com) Diversa and Du Pont in enzyme jv Diversa Corp and DuPont Bio-Based Materials have formed an alliance to develop new enzymes, which will be utilised for DuPont processes. The alliance’s first project will focus on developing enzymatic processes for making carbohydrates for DuPont’s microbial 1,3-propanediol (PDO) process. PDO is a vital ingredient in the production of DuPont’s Sorona polymer. Chemical Engineering (New York), Aug 2002, 109 (8), 19 ExxonMobil, Kellogg enter technology alliance ExxonMobil Research and Engineering Co has entered into a new worldwide technology alliance for Fluid Catalytic Cracking (FCC) technology with Kellogg Brown & Root. The companies, which plan to offer their best features to the refining industry, will jointly develop and create new technology to address the present problems faced by the FCC operators. The internationally renowned technology-based engineering and construction company Kellogg, and the leading global oil, natural gas, and petrochemical company ExxonMobil, have so far jointly designed over 200 grassroots units worldwide and have revamped hundreds of others with new and improved technology. Chemical Engineering World, Jul 2002, 37 (7), 40 Fujisawa allies with MerLion in enzyme research Fujisawa of Japan and MerLion Pharmaceutical of Singapore are to collaborate in the development of enzymes derived from naturally- occurring products. MerLion will use Fujisawa high-throughput screening (HTS) technology and certain assay systems that have been already developed at its laboratories in Singapore. Fujisawa will finance MerLion’s enzyme R&D activities through milestone payments and royalties on any enzyme products that reach marketing stage. Pharma Japan, 5-12 Aug 2002, (1806), 15 Fujitsu to license photocatalyst Fujitsu Laboratories Ltd of Akashi, Japan, is offering licences for its oxidation catalyst claimed to be highly efficient in decomposing undesirable organics. The catalyst decomposes organic substances twice as fast as conventional light- sensitive catalysts. It is made of titanium-modified calcium hydroxy- apatite and may be used for bacteria, ammonia, acetic acid, and acetaldehyde. Chemical Engineering (New York), Aug 2002, 109 (8), 21 Grace licenses FCC catalyst from ExxonMobil WR Grace and ExxonMobil Research and Engineering have signed a deal licensing ExxonMobil patents to WR Grace’s Davison Catalysts unit. The patents will be used to make and sell AdVanta, which is a new FCC catalyst being used in ExxonMobil’s refineries around the world. The catalyst was jointly developed and commercialised by Exxonmobil and WR Grace. It is claimed that the catalyst has gained commercial success in FCC units. Hydrocarbon Processing, Aug 2002, 82 (8), 92 & Japan Chemical Week, 1/8 Aug 2002, 43 (2182), 1 ICI 2Q and 1H 2002: Performance specialities For 1H 2002, the Performance Specialities division of Imperial Chemical Industries plc has reported group turnover of £422 M (£432 M in 1H 2001), EBITDA of £44 M (£55 M), and trading profit of £29 M (£39 M). For 2Q 2002, the division has reported group turnover of £222 M (£213 M in 2Q 2001), EBITDA of £22 M (£26 M), and trading profit of £15 M (£18 M). Performance Specialties results improved from the 1Q to 2Q 2002. Synetix sales were 5% ahead of 2001 for the quarter, although trading profit was lower due to continued investment in fixed costs. ICI 2Q and HY Results 2002, 1 Aug 2002, 9 (Imperial Chemical Industries plc, 20 Manchester Square, London, W1U 3AN, UK. Tel: +44 20 7009 5000. Fax: +44 20 7009 5001. Website: http://www.ici.com) JEP licenses chiral enzyme process Jülich Enzyme Products (JEP) is a small process development company formed in 1998 to sell enzymes. It has since shifted its focus from the production of enzymes to developing processes for the enzymatic reduction of keto compounds to give chiral alcohols and derivatives using oxyreductase enzymes. The company designs and licenses processes for making chiral molecules, and makes test quantities of up to 100 kg via a deal with a nearby chemical company. Rütgers Organics recently licensed an application from JEP for the synthesis of ethyl (S)4-chloro-3-hydroxybutyrate. Rütgers is using the technology licensed from JEP in commercial production of a raw material supplied OCTOBER 2002 3 FOCUS ON CATALYSTS

Diversa and Du Pont in enzyme jv

  • View
    216

  • Download
    4

Embed Size (px)

Citation preview

Page 1: Diversa and Du Pont in enzyme jv

research in developing catalyticprocesses as well as in developingprocesses. The MIT-patentedtechnology involves the preparation ofarylamines from amines and activatedaromatic compounds when apalladium or nickel catalyst and baseare present. A patent on diarylethercondensation is also covered.

Performance Chemicals Europe, Jul-Aug 2002, 17 (4),13 & Speciality Chemicals, Jul-Aug 2002, 22 (7), 6 &Chemical Engineering World, Jul 2002, 37 (7), 38

BP catalyst expertise offeredworldwide

BP is to make its new catalyst for usein fixed-bed maleic anhydrideproduction available to companiesaround the world. BP is using thecatalyst, BP-5, in the fixed-bedmanufacture of maleic anhydride frombutane. BP-5 can be used bybenzene-based producers of maleicanhydride which want to switch tobutane.

European Chemical News, 19 Aug 2002, 77 (2018), 28& Press release from BP Catalyst and Licensing, 150West Warrenville Road, Naperville, IL 60563, USA. Tel:+ 1 630 961 6506. Fax: +1 630 961 7663. Website:http://www.bp.com (7 Aug 2002)

Celanese-Novolen metallocenes pact

New and improved metallocenes, co-catalysts, and metallocene catalystsare to be jointly developed byCelanese and Novolen TechnologyHoldings in order to accelerate thecommercialization of metallocenetechnology and broaden applicationfields.

Chemical Week, 31 Jul 2002, 164 (30), 8 & EuropeanChemical News, 19 Aug 2002, 77 (2018), 26 &Plastics and Rubber Weekly, 23 Aug 2002, 7 &Chemical Market Reporter, 5 Aug 2002 (Website:http://www.chemicalmarketreporter.com)

Diversa and Du Pont in enzyme jv

Diversa Corp and DuPont Bio-BasedMaterials have formed an alliance todevelop new enzymes, which will beutilised for DuPont processes. Thealliance’s first project will focus ondeveloping enzymatic processes formaking carbohydrates for DuPont’smicrobial 1,3-propanediol (PDO)process. PDO is a vital ingredient inthe production of DuPont’s Soronapolymer.

Chemical Engineering (New York), Aug 2002, 109 (8),19

ExxonMobil, Kellogg enter technologyalliance

ExxonMobil Research andEngineering Co has entered into anew worldwide technology alliance forFluid Catalytic Cracking (FCC)technology with Kellogg Brown &Root. The companies, which plan tooffer their best features to the refiningindustry, will jointly develop andcreate new technology to address thepresent problems faced by the FCCoperators. The internationallyrenowned technology-basedengineering and constructioncompany Kellogg, and the leadingglobal oil, natural gas, andpetrochemical company ExxonMobil,have so far jointly designed over 200grassroots units worldwide and haverevamped hundreds of others withnew and improved technology.

Chemical Engineering World, Jul 2002, 37 (7), 40

Fujisawa allies with MerLion inenzyme research

Fujisawa of Japan and MerLionPharmaceutical of Singapore are tocollaborate in the development ofenzymes derived from naturally-occurring products. MerLion will useFujisawa high-throughput screening(HTS) technology and certain assaysystems that have been alreadydeveloped at its laboratories inSingapore. Fujisawa will financeMerLion’s enzyme R&D activitiesthrough milestone payments androyalties on any enzyme products thatreach marketing stage.

Pharma Japan, 5-12 Aug 2002, (1806), 15

Fujitsu to license photocatalyst

Fujitsu Laboratories Ltd of Akashi,Japan, is offering licences for itsoxidation catalyst claimed to behighly efficient in decomposingundesirable organics. The catalystdecomposes organic substancestwice as fast as conventional light-sensitive catalysts. It is made oftitanium-modified calcium hydroxy-apatite and may be used forbacteria, ammonia, acetic acid, andacetaldehyde.

Chemical Engineering (New York), Aug 2002, 109 (8),21

Grace licenses FCC catalyst fromExxonMobil

WR Grace and ExxonMobil Researchand Engineering have signed a deallicensing ExxonMobil patents to WRGrace’s Davison Catalysts unit. Thepatents will be used to make and sellAdVanta, which is a new FCC catalystbeing used in ExxonMobil’s refineriesaround the world. The catalyst wasjointly developed and commercialisedby Exxonmobil and WR Grace. It isclaimed that the catalyst has gainedcommercial success in FCC units.

Hydrocarbon Processing, Aug 2002, 82 (8), 92 &Japan Chemical Week, 1/8 Aug 2002, 43 (2182), 1

ICI 2Q and 1H 2002: Performancespecialities

For 1H 2002, the PerformanceSpecialities division of ImperialChemical Industries plc has reportedgroup turnover of £422 M (£432 M in1H 2001), EBITDA of £44 M (£55 M),and trading profit of £29 M (£39 M).For 2Q 2002, the division hasreported group turnover of £222 M(£213 M in 2Q 2001), EBITDA of £22M (£26 M), and trading profit of £15 M(£18 M). Performance Specialtiesresults improved from the 1Q to 2Q2002. Synetix sales were 5% aheadof 2001 for the quarter, althoughtrading profit was lower due tocontinued investment in fixed costs.

ICI 2Q and HY Results 2002, 1 Aug 2002, 9 (ImperialChemical Industries plc, 20 Manchester Square,London, W1U 3AN, UK. Tel: +44 20 7009 5000. Fax:+44 20 7009 5001. Website: http://www.ici.com)

JEP licenses chiral enzyme process

Jülich Enzyme Products (JEP) is asmall process development companyformed in 1998 to sell enzymes. It hassince shifted its focus from theproduction of enzymes to developingprocesses for the enzymatic reductionof keto compounds to give chiralalcohols and derivatives usingoxyreductase enzymes. The companydesigns and licenses processes formaking chiral molecules, and makestest quantities of up to 100 kg via adeal with a nearby chemical company.Rütgers Organics recently licensed anapplication from JEP for the synthesisof ethyl (S)4-chloro-3-hydroxybutyrate.Rütgers is using the technologylicensed from JEP in commercialproduction of a raw material supplied

OCTOBER 2002 3

F O C U S O N C A T A L Y S T S